SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-09-174702
Filing Date
2009-08-14
Accepted
2009-08-13 20:21:27
Documents
5
Period of Report
2009-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 231873
2 AMENDMENT NO. 2 TO THE COMPANY'S 2006 STOCK INCENTIVE PLAN dex10115.htm EX-10.115 6726
3 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 9500
4 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 9514
5 SECTION 906 CEO AND CFO CERTIFICATION dex32.htm EX-32 4548
  Complete submission text file 0001193125-09-174702.txt   263550
Mailing Address 15241 BARRANCA PARKWAY IRVINE CA 92718
Business Address 15241 BARRANCA PKWY IRVINE CA 92718 7147273157
CORTEX PHARMACEUTICALS INC/DE/ (Filer) CIK: 0000849636 (see all company filings)

IRS No.: 330303583 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-16467 | Film No.: 091012016
SIC: 2834 Pharmaceutical Preparations